Enantioselective Nano Liquid Chromatographic Separation of Racemic Pharmaceuticals: A Facile One‐Pot In Situ Preparation of Lipase‐Based Polymer Monoliths in Capillary Format

Abstract

New affinity monolithic capillary columns of 150 µm internal diameter were prepared in situ fused glass capillary via either immobilization or encapsulation of Candida antarctica lipase B (CALB) on or within polymer monoliths, respectively. The immobilized lipase-based monoliths were prepared via copolymerization of 19.1% monomers (8.9% MMA and 10.2% GMA), 19.8% EDMA, and 61.1% porogens (54.2% formamide and 6.9% 1-propanol) w/w or 20% GMA, 20% EDMA, and 60% porogens (51.6% cyclohexanol and 8.4% 1-dodecanol) in the presence of AIBN (1%) as a radical initiator. This was followed by pumping a solution of lipase through the capillaries and rinsing with potassium phosphate buffer. On the other hand, the encapsulated lipase-based monoliths were prepared via copolymerization of 20% monomers (GMA), 20% EDMA, and 60% porogens (48% 1-propanol, 6% 1,4-butanediol) or 16.4% monomers (16% BuMA, 0.4% SPMA), 23.6% EDMA, and 60% porogens (36% 1-propanol, 18% 1,4-butanediol along with 6% lipase aqueous solution in potassium phosphate buffer. The prepared capillary columns were investigated for the enantioselective nano liquid chromatographic separation of a set of different classes of racemic pharmaceuticals, namely, α- and β-blockers, antiinflammatory drugs, antifungal drugs, dopamine antagonists, norepinephrine-dopamine reuptake inhibitors, catecholamines, sedative hypnotics, diuretics, antihistaminics, anticancer drugs, and antiarrhythmic drugs. Run-to-run repeatability was quite satisfactory. The encapsulated lipase-based capillary monolith showed better enantioselective separations of most of the investigated compounds. Baseline separation was achieved for alprenolol, atenolol, bromoglutithimide, carbuterol, chloropheneramine, cizolertine carbinol, 4-hydroxy-3-methoxymandelic acid, desmethylcizolertine, nomifensine, normetanephrine, and sulconazole under reversed phase chromatographic conditions. A speculation about the understanding of the chiral recognition mechanism of lipase-based monoliths toward the investigated pharmaceuticals is discussed.

Neuroprotective Effects of Loganin on MPTP‐Induced Parkinson's Disease Mice: Neurochemistry, Glial Reaction and Autophagy Studies

“…Striatal dopamine (DA) was quantified by high performance liquid chromatography (HPLC) using previous methods with moderate adjustment [Hubbard et al, ; Ahmed and Ghanem, ]. Waters separation system (Waters 2695) was applied using an Atlantis T3 column (150 mm × 4.6 mm, 5 µm, Waters) with a fluorescence detector (Waters, 2475).…”

An insight into chiral monolithic stationary phases for enantioselective high‐performance liquid chromatography applications

“…The enantioselective analysis was investigated for a set of pharmaceutical compounds such as β‐blockers, α‐blockers, antiinflammatory drugs, antifungal drugs, dopamine antagonists, norepinephrine dopamine reuptake inhibitor, catecholamines, sedative hypnotics, diuretic, and antihistamines. The encapsulated monolithic column proved to be advantageous for several categories of chiral drugs .…”

Application of Carbon Nanotubes in Chiral and Achiral Separations of Pharmaceuticals, Biologics and Chemicals

“…The second mixture composed of ‘16.4% monomers (0.4% sulfpropyl methacrylate, 16% butylmethacrylate), 23.6% crosslinker ethylene glycol dimethacrylate and 60% porogens’ the same as the first mixture. [ 46 ] The ratio of 40:60 w / w of monomers to porogens has been selected to provide a monolith with good permeability, reasonable mechanical stability and high surface area [ 103 ]. Three different chromatographic modes were used; namely reversed, normal and polar organic mobile phase [ 46 ].…”